Skip to main content

Table 1 Mutation frequencies of genes in pathways

From: Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics

Pathway

Number of non-silent somatic mutations

Mutation frequency (%, n = 96)

Mutation frequency in GCB subtype (%, n = 36)

Mutation frequency in non-GCB subtype (%, n = 60)

P

FDR

BCR signaling

 CD79A

2

2

3

2

1.000

1.000

 CD79B

23

18

6

25

0.016

0.536

 BTK

3

3

6

2

0.650

1.000

 CARD11

12

10

14

8

0.605

1.000

 MALT1

5

2

3

2

1.000

1.000

 BCL10

5

5

6

5

1.000

1.000

 PRKCB

6

5

3

7

0.722

1.000

 TCF3

4

4

6

3

1.000

1.000

 ID3

0

0

0

0

NA

NA

TLR signaling

 MYD88

20

21

22

20

0.795

1.000

NF-κB signaling

 TNFAIP3

7

7

3

10

0.362

1.000

 TRAF2

2

1

0

2

1.000

1.000

 TRAF5

2

2

0

3

0.526

1.000

 MAP3K7

0

0

0

0

NA

NA

 IKBKB

1

1

0

2

1.000

1.000

 TNFRSF11A

1

1

0

2

1.000

1.000

 TRAF3

0

0

0

0

NA

NA

 BIRC3

4

4

8

2

0.291

1.000

 MAP3K14

1

1

3

0

0.375

1.000

 NFKBIA

5

4

6

3

1.000

1.000

NOTCH signaling

 NOTCH1

8

8

8

8

1.000

1.000

 NOTCH2

9

9

8

10

1.000

1.000

 SPEN

18

17

14

18

0.572

1.000

 FBXW7

5

4

3

5

1.000

1.000

PI3K/AKT signaling

 PIK3CA

2

2

3

2

1.000

1.000

 PIK3CD

1

1

3

0

0.375

1.000

 PIK3CG

4

4

3

5

1.000

1.000

 PIK3R1

2

2

3

2

1.000

1.000

 PIK3R2

2

2

0

3

0.526

1.000

 AKT1

0

0

0

0

NA

NA

 AKT2

1

1

0

2

1.000

1.000

 AKT3

3

3

3

3

1.000

1.000

 PTEN

10

7

11

5

0.478

1.000

 MTOR

4

4

6

3

1.000

1.000

 SGK1

33

13

19

8

0.202

1.000

JAK/STAT signaling

 JAK1

1

1

0

2

1.000

1.000

 JAK2

4

4

3

5

1.000

1.000

 JAK3

2

2

6

0

0.138

1.000

 STAT3

10

7

14

3

0.128

1.000

 STAT5A

2

1

0

2

1.000

1.000

 STAT5B

0

0

0

0

NA

NA

 STAT6

8

7

8

7

1.000

1.000

 SOCS1

86

24

28

22

0.497

1.000

 PTPN1

1

1

3

0

0.375

1.000

 MPL

1

1

3

0

0.375

1.000

MAPK signaling

 NRAS

1

1

3

0

0.375

1.000

 KRAS

0

0

0

0

NA

NA

 BRAF

4

4

3

5

1.000

1.000

S1P2 signaling

 GNA13

9

7

14

3

0.128

1.000

 S1PR2

4

4

3

5

1.000

1.000

Epigenetic regulation

 ARID1A

11

10

17

7

0.227

1.000

 CREBBP

13

13

14

12

1.000

1.000

 EP300

6

5

3

7

0.722

1.000

 DNMT3A

2

2

0

3

0.526

1.000

 EZH2

5

4

8

2

0.291

1.000

 HDAC1

2

2

6

0

0.138

1.000

 HDAC4

4

3

3

3

1.000

1.000

 HDAC7

5

3

6

2

0.650

1.000

 HIST1H1C

12

9

19

3

0.024

0.536

 HIST1H1E

27

18

28

12

0.045

0.7538

 IDH1

0

0

0

0

NA

NA

 IDH2

1

1

0

2

1.000

1.000

 KDM2B

7

6

3

8

0.514

1.000

 KMT2C

16

16

11

18

0.345

1.000

 KMT2D

36

30

33

28

0.605

1.000

 MEF2B

8

8

6

10

0.703

1.000

 MEF2C

1

1

0

2

1.000

1.000

 SETD2

3

3

6

2

0.650

1.000

 TET2

16

11

17

8

0.363

1.000

Immunity

 B2M

11

10

17

7

0.227

1.000

 CD58

7

6

8

5

0.828

1.000

 CD70

14

11

11

12

1.000

1.000

 CIITA

14

13

6

17

0.202

1.000

 TNFRSF14

11

10

22

3

0.010

0.536

  1. Abbreviation: GCB germinal center B-cell-like, FDR false discovery rate, NA not available